<VariationArchive RecordType="classified" VariationID="560081" VariationName="Single allele" VariationType="Deletion" Accession="VCV000560081" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-10-15" DateCreated="2018-08-26" MostRecentSubmission="2022-12-11">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="550797" VariationID="560081">
      <GeneList>
        <Gene Symbol="B3GALT2" FullName="beta-1,3-galactosyltransferase 2" GeneID="8707" HGNC_ID="HGNC:917" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="193178730" stop="193186613" display_start="193178730" display_stop="193186613" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="193147859" stop="193155742" display_start="193147859" display_stop="193155742" Strand="-" />
          </Location>
          <OMIM>603018</OMIM>
        </Gene>
        <Gene Symbol="CDC73" FullName="cell division cycle 73" GeneID="79577" HGNC_ID="HGNC:16783" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="193122031" stop="193254815" display_start="193122031" display_stop="193254815" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="193091087" stop="193223944" display_start="193091087" display_stop="193223944" Strand="+" />
          </Location>
          <OMIM>607393</OMIM>
          <Haploinsufficiency last_evaluated="2022-04-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CDC73">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2022-04-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CDC73">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="GLRX2" FullName="glutaredoxin 2" GeneID="51022" HGNC_ID="HGNC:16065" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="193096465" stop="193106114" display_start="193096465" display_stop="193106114" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="193065594" stop="193075243" display_start="193065594" display_stop="193075243" Strand="-" />
          </Location>
          <OMIM>606820</OMIM>
        </Gene>
        <Gene Symbol="LINC01031" FullName="long intergenic non-protein coding RNA 1031" GeneID="101929184" HGNC_ID="HGNC:49017" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="193304745" stop="193365953" display_start="193304745" display_stop="193365953" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LINC02770" FullName="long intergenic non-protein coding RNA 2770" GeneID="107985457" HGNC_ID="HGNC:54290" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="191732686" stop="192011260" display_start="191732686" display_stop="192011260" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC111556116" FullName="HNF1 motif-containing MPRA enhancer 26" GeneID="111556116" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="192701091" stop="192701235" display_start="192701091" display_stop="192701235" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC120893169" FullName="MED14-independent group 3 enhancer GRCh37_chr1:193324401-193325600" GeneID="120893169" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="193355219" stop="193356470" display_start="193355219" display_stop="193356470" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC122149332" FullName="Sharpr-MPRA regulatory region 5305" GeneID="122149332" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="192153219" stop="192153513" display_start="192153219" display_stop="192153513" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC122149333" FullName="Sharpr-MPRA regulatory region 7925" GeneID="122149333" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="193105203" stop="193105592" display_start="193105203" display_stop="193105592" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC122149334" FullName="Sharpr-MPRA regulatory region 4625" GeneID="122149334" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="193115679" stop="193115973" display_start="193115679" display_stop="193115973" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC126805961" FullName="BRD4-independent group 4 enhancer GRCh37_chr1:192795712-192796911" GeneID="126805961" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="192826582" stop="192827781" display_start="192826582" display_stop="192827781" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC126805962" FullName="P300/CBP strongly-dependent group 1 enhancer GRCh37_chr1:193583455-193584654" GeneID="126805962" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="193614325" stop="193615524" display_start="193614325" display_stop="193615524" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129388703" FullName="MPRA-validated peak601 silencer" GeneID="129388703" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="191961706" stop="191961906" display_start="191961706" display_stop="191961906" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129388704" FullName="MPRA-validated peak603 silencer" GeneID="129388704" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="192165105" stop="192165305" display_start="192165105" display_stop="192165305" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129388705" FullName="MPRA-validated peak604 silencer" GeneID="129388705" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="192201405" stop="192201605" display_start="192201405" display_stop="192201605" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129388706" FullName="MPRA-validated peak605 silencer" GeneID="129388706" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="192204786" stop="192204986" display_start="192204786" display_stop="192204986" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129388707" FullName="MPRA-validated peak609 silencer" GeneID="129388707" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q31.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="194076746" stop="194076946" display_start="194076746" display_stop="194076946" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129388708" FullName="MPRA-validated peak610 silencer" GeneID="129388708" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q31.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="194190165" stop="194190365" display_start="194190165" display_stop="194190365" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129388709" FullName="MPRA-validated peak612 silencer" GeneID="129388709" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q31.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="194289566" stop="194289766" display_start="194289566" display_stop="194289766" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129388710" FullName="MPRA-validated peak613 silencer" GeneID="129388710" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q31.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="194338406" stop="194338606" display_start="194338406" display_stop="194338606" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129388711" FullName="MPRA-validated peak614 silencer" GeneID="129388711" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q31.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="194338726" stop="194338926" display_start="194338726" display_stop="194338926" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129388712" FullName="MPRA-validated peak616 silencer" GeneID="129388712" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q31.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="194387106" stop="194387306" display_start="194387106" display_stop="194387306" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129388713" FullName="MPRA-validated peak617 silencer" GeneID="129388713" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q31.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="194427146" stop="194427346" display_start="194427146" display_stop="194427346" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129932134" FullName="ATAC-STARR-seq lymphoblastoid active region 2257" GeneID="129932134" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="192516638" stop="192516757" display_start="192516638" display_stop="192516757" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129932135" FullName="ATAC-STARR-seq lymphoblastoid active region 2258" GeneID="129932135" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="192516818" stop="192516937" display_start="192516818" display_stop="192516937" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129932136" FullName="ATAC-STARR-seq lymphoblastoid silent region 1651" GeneID="129932136" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="192518820" stop="192518999" display_start="192518820" display_stop="192518999" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129932137" FullName="ATAC-STARR-seq lymphoblastoid active region 2259" GeneID="129932137" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="192545150" stop="192545209" display_start="192545150" display_stop="192545209" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129932138" FullName="ATAC-STARR-seq lymphoblastoid active region 2260" GeneID="129932138" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="192551479" stop="192551558" display_start="192551479" display_stop="192551558" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129932139" FullName="ATAC-STARR-seq lymphoblastoid active region 2261" GeneID="129932139" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="192559816" stop="192559865" display_start="192559816" display_stop="192559865" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129932140" FullName="ATAC-STARR-seq lymphoblastoid active region 2262" GeneID="129932140" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="192575618" stop="192575697" display_start="192575618" display_stop="192575697" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129932141" FullName="ATAC-STARR-seq lymphoblastoid active region 2263" GeneID="129932141" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="192579334" stop="192579583" display_start="192579334" display_stop="192579583" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129932142" FullName="ATAC-STARR-seq lymphoblastoid silent region 1652" GeneID="129932142" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="192807490" stop="192807579" display_start="192807490" display_stop="192807579" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129932143" FullName="ATAC-STARR-seq lymphoblastoid silent region 1653" GeneID="129932143" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="192808516" stop="192808725" display_start="192808516" display_stop="192808725" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129932144" FullName="ATAC-STARR-seq lymphoblastoid active region 2264" GeneID="129932144" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="192809056" stop="192809275" display_start="192809056" display_stop="192809275" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129932145" FullName="ATAC-STARR-seq lymphoblastoid silent region 1654" GeneID="129932145" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="192810233" stop="192810292" display_start="192810233" display_stop="192810292" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129932146" FullName="ATAC-STARR-seq lymphoblastoid active region 2265" GeneID="129932146" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="193058712" stop="193059021" display_start="193058712" display_stop="193059021" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129932147" FullName="ATAC-STARR-seq lymphoblastoid active region 2269" GeneID="129932147" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="193216991" stop="193217050" display_start="193216991" display_stop="193217050" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129932148" FullName="ATAC-STARR-seq lymphoblastoid active region 2270" GeneID="129932148" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="193437871" stop="193437930" display_start="193437871" display_stop="193437930" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129932149" FullName="ATAC-STARR-seq lymphoblastoid active region 2271" GeneID="129932149" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="193539855" stop="193540064" display_start="193539855" display_stop="193540064" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129932150" FullName="ATAC-STARR-seq lymphoblastoid active region 2272" GeneID="129932150" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="193540315" stop="193540384" display_start="193540315" display_stop="193540384" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129932151" FullName="ATAC-STARR-seq lymphoblastoid active region 2273" GeneID="129932151" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q31.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="194280047" stop="194280316" display_start="194280047" display_stop="194280316" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC132088601" FullName="Neanderthal introgressed variant-containing enhancer experimental_1434" GeneID="132088601" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q31.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="193846721" stop="193846890" display_start="193846721" display_stop="193846890" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC132088602" FullName="Neanderthal introgressed variant-containing enhancer experimental_1503" GeneID="132088602" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q31.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="193965889" stop="193966058" display_start="193965889" display_stop="193966058" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC132090670" FullName="Neanderthal introgressed variant-containing enhancer experimental_1475" GeneID="132090670" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q31.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="193907779" stop="193907948" display_start="193907779" display_stop="193907948" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="MIR1278" FullName="microRNA 1278" GeneID="100302163" HGNC_ID="HGNC:35356" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="193136503" stop="193136583" display_start="193136503" display_stop="193136583" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="MIR4426" FullName="microRNA 4426" GeneID="100616345" HGNC_ID="HGNC:41848" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="192716328" stop="192716390" display_start="192716328" display_stop="192716390" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="RGS1" FullName="regulator of G protein signaling 1" GeneID="5996" HGNC_ID="HGNC:9991" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="192575773" stop="192580024" display_start="192575773" display_stop="192580024" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="192544856" stop="192549158" display_start="192544856" display_stop="192549158" Strand="+" />
          </Location>
          <OMIM>600323</OMIM>
        </Gene>
        <Gene Symbol="RGS13" FullName="regulator of G protein signaling 13" GeneID="6003" HGNC_ID="HGNC:9995" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="192636147" stop="192660311" display_start="192636147" display_stop="192660311" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="192605267" stop="192629440" display_start="192605267" display_stop="192629440" Strand="+" />
          </Location>
          <OMIM>607190</OMIM>
        </Gene>
        <Gene Symbol="RGS18" FullName="regulator of G protein signaling 18" GeneID="64407" HGNC_ID="HGNC:14261" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="192158462" stop="192185815" display_start="192158462" display_stop="192185815" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="192127591" stop="192154944" display_start="192127591" display_stop="192154944" Strand="+" />
          </Location>
          <OMIM>607192</OMIM>
        </Gene>
        <Gene Symbol="RGS2" FullName="regulator of G protein signaling 2" GeneID="5997" HGNC_ID="HGNC:9998" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="192809039" stop="192812275" display_start="192809039" display_stop="192812275" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="192778168" stop="192781406" display_start="192778168" display_stop="192781406" Strand="+" />
          </Location>
          <OMIM>600861</OMIM>
        </Gene>
        <Gene Symbol="RGS2-AS1" FullName="RSG2 antisense RNA 1" GeneID="102724954" HGNC_ID="HGNC:49018" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="192935744" stop="192948257" display_start="192935744" display_stop="192948257" Strand="-" />
          </Location>
        </Gene>
        <Gene Symbol="RGS21" FullName="regulator of G protein signaling 21" GeneID="431704" HGNC_ID="HGNC:26839" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="192316992" stop="192367285" display_start="192316992" display_stop="192367285" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="192286121" stop="192336414" display_start="192286121" display_stop="192336414" Strand="+" />
          </Location>
          <OMIM>612407</OMIM>
        </Gene>
        <Gene Symbol="RO60" FullName="Ro60, Y RNA binding protein" GeneID="6738" HGNC_ID="HGNC:11313" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="193059612" stop="193091777" display_start="193059612" display_stop="193091777" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="193028551" stop="193060906" display_start="193028551" display_stop="193060906" Strand="+" />
          </Location>
          <OMIM>600063</OMIM>
        </Gene>
        <Gene Symbol="SCARNA18B" FullName="small Cajal body-specific RNA 18B" GeneID="107397392" HGNC_ID="HGNC:52236" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="193057281" stop="193057415" display_start="193057281" display_stop="193057415" Strand="-" />
          </Location>
        </Gene>
        <Gene Symbol="UCHL5" FullName="ubiquitin C-terminal hydrolase L5" GeneID="51377" HGNC_ID="HGNC:19678" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="193012254" stop="193060076" display_start="193012254" display_stop="193060076" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="192981495" stop="193029236" display_start="192981495" display_stop="193029236" Strand="-" />
          </Location>
          <OMIM>610667</OMIM>
        </Gene>
      </GeneList>
      <Name>Single allele</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1q31.2-31.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="191919194" stop="194615758" display_start="191919194" display_stop="194615758" variantLength="2696565" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="191888324" stop="194584888" display_start="191888324" display_stop="194584888" variantLength="2696565" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.191919194_194615758del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.191919194_194615758del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.191888324_194584888del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.191888324_194584888del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="Single allele AND multiple conditions" Accession="RCV000677958" Version="2">
        <ClassifiedConditionList TraitSetID="10560">
          <ClassifiedCondition DB="MedGen" ID="C1840402">Hyperparathyroidism 1</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1704981">Hyperparathyroidism 2 with jaw tumors</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0687150">Parathyroid carcinoma</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-04-25" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2017-04-25" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2018-08-26" MostRecentSubmission="2022-12-11">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">28774260</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="10560" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3270" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Parathyroid cancer</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parathyroid gland carcinoma</ElementValue>
                <XRef ID="MONDO:0012004" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Parathyroid carcinoma</ElementValue>
                <XRef ID="Parathyroid+carcinoma/5598" DB="Genetic Alliance" />
                <XRef ID="HP:0006780" DB="Human Phenotype Ontology" />
                <XRef ID="255037004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CDC73-Related Parathyroid Carcinoma</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PRTC</ElementValue>
                <XRef Type="MIM" ID="608266" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The spectrum of CDC73-related disorders includes the following phenotypes: Hyperparathyroidism-jaw tumor (HPT-JT) syndrome. Primary hyperparathyroidism, the main finding of HPT-JT syndrome, occurs in up to 95% of affected individuals; onset is typically in late adolescence or early adulthood. HPT-JT-associated primary hyperparathyroidism is usually caused by a single parathyroid adenoma. In approximately 10%-15% of individuals, primary hyperparathyroidism is caused by parathyroid carcinoma. Ossifying fibromas of the mandible or maxilla, also known as cementifying fibromas and cemento-ossifying fibromas, occur in 30%-40% of individuals with HPT-JT syndrome. Although benign, these tumors can be locally aggressive and may continue to enlarge if not treated. Approximately 20% of individuals with HPT-JT syndrome have kidney lesions, most commonly cysts; renal hamartomas and (more rarely) Wilms tumor have also been reported. Benign and malignant uterine tumors appear to be common in women with HPT-JT syndrome. Parathyroid carcinoma. Most parathyroid carcinomas are functional, resulting in hyperparathyroidism and a high serum calcium level; however, nonfunctioning parathyroid carcinomas are also rarely described in individuals with a CDC73-related disorder. A germline CDC73 pathogenic variant has been identified in 20%-29% of individuals with apparently sporadic parathyroid carcinoma. Familial isolated hyperparathyroidism (FIHP). FIHP is characterized by primary hyperparathyroidism without other associated syndromic features. Individuals with CDC73-related FIHP tend to have a more severe clinical presentation and younger age of onset than individuals with FIHP in whom a CDC73 pathogenic variant has not been identified.</Attribute>
                <XRef ID="NBK3789" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7329" />
                <XRef ID="7329" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301744</ID>
                <ID Source="BookShelf">NBK3789</ID>
              </Citation>
              <XRef ID="143" DB="Orphanet" />
              <XRef ID="C0687150" DB="MedGen" />
              <XRef ID="MONDO:0012004" DB="MONDO" />
              <XRef Type="MIM" ID="608266" DB="OMIM" />
              <XRef Type="primary" ID="HP:0006780" DB="Human Phenotype Ontology" />
            </Trait>
            <Trait ID="1734" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">HYPERPARATHYROIDISM, FAMILIAL ISOLATED PRIMARY</ElementValue>
                <XRef Type="MIM" ID="145000" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613733.0031" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hyperparathyroidism 1</ElementValue>
                <XRef ID="319534" DB="GeneTests" />
                <XRef ID="Hyperparathyroidism+1/8597" DB="Genetic Alliance" />
                <XRef ID="MONDO:0007767" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">FIHP</ElementValue>
                <XRef Type="MIM" ID="145000" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">HRPT1</ElementValue>
                <XRef Type="MIM" ID="145000" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18253" />
                <XRef ID="18253" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">CDC73-Related Disorders</Attribute>
                <XRef ID="226120" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The spectrum of CDC73-related disorders includes the following phenotypes: Hyperparathyroidism-jaw tumor (HPT-JT) syndrome. Primary hyperparathyroidism, the main finding of HPT-JT syndrome, occurs in up to 95% of affected individuals; onset is typically in late adolescence or early adulthood. HPT-JT-associated primary hyperparathyroidism is usually caused by a single parathyroid adenoma. In approximately 10%-15% of individuals, primary hyperparathyroidism is caused by parathyroid carcinoma. Ossifying fibromas of the mandible or maxilla, also known as cementifying fibromas and cemento-ossifying fibromas, occur in 30%-40% of individuals with HPT-JT syndrome. Although benign, these tumors can be locally aggressive and may continue to enlarge if not treated. Approximately 20% of individuals with HPT-JT syndrome have kidney lesions, most commonly cysts; renal hamartomas and (more rarely) Wilms tumor have also been reported. Benign and malignant uterine tumors appear to be common in women with HPT-JT syndrome. Parathyroid carcinoma. Most parathyroid carcinomas are functional, resulting in hyperparathyroidism and a high serum calcium level; however, nonfunctioning parathyroid carcinomas are also rarely described in individuals with a CDC73-related disorder. A germline CDC73 pathogenic variant has been identified in 20%-29% of individuals with apparently sporadic parathyroid carcinoma. Familial isolated hyperparathyroidism (FIHP). FIHP is characterized by primary hyperparathyroidism without other associated syndromic features. Individuals with CDC73-related FIHP tend to have a more severe clinical presentation and younger age of onset than individuals with FIHP in whom a CDC73 pathogenic variant has not been identified.</Attribute>
                <XRef ID="NBK3789" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301744</ID>
                <ID Source="BookShelf">NBK3789</ID>
              </Citation>
              <XRef ID="99879" DB="Orphanet" />
              <XRef ID="C1840402" DB="MedGen" />
              <XRef ID="MONDO:0007767" DB="MONDO" />
              <XRef Type="MIM" ID="145000" DB="OMIM" />
            </Trait>
            <Trait ID="5289" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">HYPERPARATHYROIDISM, FAMILIAL PRIMARY, WITH MULTIPLE OSSIFYING JAW FIBROMAS</ElementValue>
                <XRef Type="MIM" ID="145001" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HYPERPARATHYROIDISM-JAW TUMOR SYNDROME, HEREDITARY</ElementValue>
                <XRef Type="MIM" ID="145001" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hyperparathyroidism 2</ElementValue>
                <XRef ID="Hyperparathyroidism+2/8598" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hyperparathyroidism 2 with jaw tumors</ElementValue>
                <XRef ID="MONDO:0007768" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HPT-JT</ElementValue>
                <XRef Type="MIM" ID="145001" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">HRPT2</ElementValue>
                <XRef Type="MIM" ID="145001" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">CDC73-Related Disorders</Attribute>
                <XRef ID="226120" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10829" />
                <XRef ID="10829" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The spectrum of CDC73-related disorders includes the following phenotypes: Hyperparathyroidism-jaw tumor (HPT-JT) syndrome. Primary hyperparathyroidism, the main finding of HPT-JT syndrome, occurs in up to 95% of affected individuals; onset is typically in late adolescence or early adulthood. HPT-JT-associated primary hyperparathyroidism is usually caused by a single parathyroid adenoma. In approximately 10%-15% of individuals, primary hyperparathyroidism is caused by parathyroid carcinoma. Ossifying fibromas of the mandible or maxilla, also known as cementifying fibromas and cemento-ossifying fibromas, occur in 30%-40% of individuals with HPT-JT syndrome. Although benign, these tumors can be locally aggressive and may continue to enlarge if not treated. Approximately 20% of individuals with HPT-JT syndrome have kidney lesions, most commonly cysts; renal hamartomas and (more rarely) Wilms tumor have also been reported. Benign and malignant uterine tumors appear to be common in women with HPT-JT syndrome. Parathyroid carcinoma. Most parathyroid carcinomas are functional, resulting in hyperparathyroidism and a high serum calcium level; however, nonfunctioning parathyroid carcinomas are also rarely described in individuals with a CDC73-related disorder. A germline CDC73 pathogenic variant has been identified in 20%-29% of individuals with apparently sporadic parathyroid carcinoma. Familial isolated hyperparathyroidism (FIHP). FIHP is characterized by primary hyperparathyroidism without other associated syndromic features. Individuals with CDC73-related FIHP tend to have a more severe clinical presentation and younger age of onset than individuals with FIHP in whom a CDC73 pathogenic variant has not been identified.</Attribute>
                <XRef ID="NBK3789" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301471</ID>
                <ID Source="BookShelf">NBK1294</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301744</ID>
                <ID Source="BookShelf">NBK3789</ID>
              </Citation>
              <XRef ID="99880" DB="Orphanet" />
              <XRef ID="C1704981" DB="MedGen" />
              <XRef ID="MONDO:0007768" DB="MONDO" />
              <XRef Type="MIM" ID="145001" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1567937" SubmissionDate="2018-04-18" DateLastUpdated="2022-12-11" DateCreated="2018-08-26">
        <ClinVarSubmissionID localKey="ADMI00199" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000804113" DateUpdated="2022-12-11" DateCreated="2018-08-26" Type="SCV" Version="2" SubmitterName="Geisinger Autism and Developmental Medicine Institute, Geisinger Health System" OrgID="506174" OrganizationCategory="clinic" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-04-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">28774260</ID>
          </Citation>
          <Comment>This deletion was identified in a 13 year old female with borderline intellectual disability, motor coordination disorder, ADHD, skull anomalies, history of neonatal seizure, and amblyopia. The patient's biological parents are unavailable for parental studies. There is no known family history of parathyroid cancer or thyroid disease. Of note, the patient also carries a pathogenic deletion at 16p11.2.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG CNV Guidelines, 2011</Attribute>
          <Citation>
            <ID Source="PubMed">21681106</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">10</Age>
              <Age Type="maximum" age_unit="years">19</Age>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>provider interpretation</MethodType>
              <MethodAttribute>
                <Attribute Type="StructVarMethodType">Oligo array</Attribute>
              </MethodAttribute>
              <ObsMethodAttribute>
                <Attribute Type="TestingLaboratory" dateValue="2017-04-25" integerValue="26957">GeneDx</Attribute>
                <Comment>Pathogenic</Comment>
              </ObsMethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="SecondaryFinding">no</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Intellectual disability</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0001249" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Poor motor coordination</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0002275" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Attention deficit hyperactivity disorder</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0007018" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Amblyopia</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0000646" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Deletion</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="1" start="191888324" stop="194584888" variantLength="2696565" />
          </Location>
          <AttributeSet>
            <Attribute Type="AbsoluteCopyNumber">1</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="145000" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="145001" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="608266" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB3918644</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1567937" TraitType="Disease" MappingType="XRef" MappingValue="145001" MappingRef="OMIM">
        <MedGen CUI="C1704981" Name="Hyperparathyroidism 2 with jaw tumors" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1567937" TraitType="Finding" MappingType="Name" MappingValue="Poor motor coordination" MappingRef="Preferred">
        <MedGen CUI="C1848453" Name="Poor motor coordination" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1567937" TraitType="Disease" MappingType="XRef" MappingValue="608266" MappingRef="OMIM">
        <MedGen CUI="C0687150" Name="Parathyroid carcinoma" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1567937" TraitType="Finding" MappingType="Name" MappingValue="Attention deficit hyperactivity disorder" MappingRef="Preferred">
        <MedGen CUI="C1263846" Name="Attention deficit hyperactivity disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1567937" TraitType="Finding" MappingType="Name" MappingValue="Amblyopia" MappingRef="Preferred">
        <MedGen CUI="C0002418" Name="Amblyopia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1567937" TraitType="Disease" MappingType="XRef" MappingValue="145000" MappingRef="OMIM">
        <MedGen CUI="C1840402" Name="Hyperparathyroidism 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1567937" TraitType="Finding" MappingType="Name" MappingValue="Intellectual disability" MappingRef="Preferred">
        <MedGen CUI="C3714756" Name="Intellectual disability" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

